• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Osteoarthritis Pipeline Capsule - 2013 Product Image

Global Osteoarthritis Pipeline Capsule - 2013

  • ID: 2552131
  • April 2013
  • Region: Global
  • 25 pages
  • Fore Pharma

Fore Pharma’s latest report ‘Global Osteoarthritis Pipeline Capsule – 2013’ provides up-to-date information on key Research and Development (R&D) activities in the global osteoarthritis market. It covers active osteoarthritis pipeline molecules in clinical trials, preclinical research, and drug discovery.

This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The scope of the report includes information on osteoarthritis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Osteoarthritis pipeline molecules licensing activities are also covered in this report.

Key Features of the Report:
- Osteoarthritis Pipeline Overview
- Osteoarthritis Phase 3 Clinical Trial Pipeline
- Osteoarthritis Phase 2 Clinical Trial Pipeline
- Osteoarthritis Phase 1 Clinical Trial Pipeline
- Osteoarthritis Preclinical Research Pipeline
- Osteoarthritis Drug Discovery Stage Pipeline
- Osteoarthritis Pipeline in the U.S.
- Osteoarthritis Pipeline in Europe
- Licensing Activities in Global Osteoarthritis Market

1. Osteoarthritis - Disease Overview
2. Osteoarthritis Pipeline Overview
3. Osteoarthritis Pipeline by Geography
3a. Osteoarthritis Pipeline in Matured Markets
4. Osteoarthritis Phase 3 Clinical Trial Pipeline Insights
4a. Osteoarthritis Phase 3 Clinical Trial Pipeline (North America)
4b. Osteoarthritis Phase 3 Clinical Trial Pipeline (Europe)
4c. Osteoarthritis Phase 3 Clinical Trial Pipeline (ROW)
5. Osteoarthritis Phase 2 Clinical Trial Pipeline Insights
5a. Osteoarthritis Phase 2 Clinical Trial Pipeline (North America)
5b. Osteoarthritis Phase 2 Clinical Trial Pipeline (Europe)
5c. Osteoarthritis Phase 2 Clinical Trial Pipeline (ROW)
6. Osteoarthritis Phase 1 Clinical Trial Pipeline Insights
6a. Osteoarthritis Phase 1 Clinical Trial Pipeline (North America)
6b. Osteoarthritis Phase 1 Clinical Trial Pipeline (Europe)
6c. Osteoarthritis Phase 1 Clinical Trial Pipeline (ROW)
7. Osteoarthritis Preclinical Research Pipeline Insights
7a. Osteoarthritis Preclinical Research Pipeline (North America)
7b. Osteoarthritis Preclinical Research Pipeline (Europe)
7c. Osteoarthritis Preclinical Research Pipeline (ROW)
8. Osteoarthritis Drug Discovery Pipeline Insights
8a. Osteoarthritis Drug Discovery Pipeline (North America)
8b. Osteoarthritis Drug Discovery Pipeline (Europe)
8c. Osteoarthritis Drug Discovery Pipeline (ROW)
9. Osteoarthritis Market – Licensing Activities
10. Appendix
11. Research Methodology
Table 1: Osteoarthritis Phase 3 Clinical Trial Pipeline in North America (2013)
Table 2: Osteoarthritis Phase 3 Clinical Trial Pipeline in Europe (2013)
Table 3: Osteoarthritis Phase 3 Clinical Trial Pipeline in ROW (2013)
Table 4: Osteoarthritis Phase 2 Clinical Trial Pipeline in North America (2013)
Table 5: Osteoarthritis Phase 2 Clinical Trial Pipeline in Europe (2013)
Table 6: Osteoarthritis Phase 2 Clinical Trial Pipeline in ROW (2013)
Table 7: Osteoarthritis Phase 1 Clinical Trial Pipeline in North America (2013)
Table 8: Osteoarthritis Phase 1 Clinical Trial Pipeline in Europe (2013)
Table 9: Osteoarthritis Phase 1 Clinical Trial Pipeline in ROW (2013)
Table 10: Osteoarthritis Preclinical Research Pipeline in North America (2013)
Table 11: Osteoarthritis Preclinical Research Pipeline in Europe (2013)
Table 12: Osteoarthritis Preclinical Research Pipeline in ROW (2013)
Table 13: Osteoarthritis Drug Discovery Pipeline in North America (2013)
Table 14: Osteoarthritis Drug Discovery Pipeline in Europe (2013)
Table 15: Osteoarthritis Drug Discovery Pipeline in ROW (2013)
Table 16: Key Licensing Activities in Global Osteoarthritis Market
Figure 1: Osteoarthritis Pipeline Molecules by Clinical Trial Stages (2013)
Figure 2: Osteoarthritis Pipeline Activities by Geography (2013)
Figure 3: Osteoarthritis Pipeline Activities in Matured Markets (2013)
Figure 4: Osteoarthritis Phase 3 Clinical Trial Activities by Geography (2013)
Figure 5: Osteoarthritis Phase 2 Clinical Trial Activities by Geography (2013)
Figure 6: Osteoarthritis Phase 1 Clinical Trial Activities by Geography (2013)
Figure 7: Osteoarthritis Preclinical Research Activities by Geography (2013)
Figure 8: Osteoarthritis Drug Discovery Activities by Geography (2013)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos